O24.434
Gestational diabetes mellitus in the puerperium, insulin controlled
Clinical Classification Guidelines
Medical Intelligence & Overview
Gestational diabetes mellitus (GDM) is a type of diabetes that develops during pregnancy. This condition affects how your cells use sugar (glucose) and can lead to high blood sugar levels. Specifically, ICD-10 code O24.434 pertains to gestational diabetes that occurs during the puerperium period — the time after childbirth — which is managed with insulin. Monitoring and managing GDM is crucial for maternal and fetal health, and understanding this condition can help new mothers navigate their postpartum health with clarity.
Causes & Symptoms
Clinical Causes: Hormonal changes during pregnancy that interfere with insulin action Pre-existing insulin resistance needing additional management during pregnancy Obesity or excessive weight gain during pregnancy Family history of diabetes or previous instances of gestational diabetes Age over 25 years at the time of pregnancy Certain medical conditions like polycystic ovary syndrome (PCOS)
Key Symptoms: Increased thirst and frequent urination Fatigue or feeling unusually tired Blurred vision or difficulty seeing clearly Recurrent infections, especially of the bladder and skin Unexplained weight loss (less common in GDM)
Diagnostic & Treatment
Diagnosis Path: Gestational diabetes is typically diagnosed during routine screening tests in pregnancy, especially between 24 and 28 weeks of gestation. The common diagnostic methods include:
Treatment Protocols: Management of GDM aims to control blood sugar levels to reduce health risks for both mother and baby. When insulin control is indicated, healthcare providers recommend:
Clinical Advice & FAQs
Billing Guidance
Is O24.434 a billable ICD-10 code?
Yes, O24.434 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O24.434?
Clinical documentation must specify the nature of Gestational diabetes mellitus in the puerperium, insulin controlled and any associated comorbidities for accurate reporting.
Cite this Clinical Reference